Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5602)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2021 (publication date) through Apr 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qi MM, He PZ, Zhang L, Dong WG. STAT3-mediated activation of mitochondrial pathway contributes to antitumor effect of dihydrotanshinone I in esophageal squamous cell carcinoma cells. World J Gastrointest Oncol 2021; 13(8): 893-914 [PMID: 34457194 DOI: 10.4251/wjgo.v13.i8.893] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i8/893.htm |
| Number | Citing Articles |
| 1 |
Yongbo Lin, Li Ma, Hanliang Dan, Gang Chen, Jian Dai, Liang Xu, Yuqi Liu. MiR-107-3p Knockdown Alleviates Endothelial Injury in Sepsis via Kallikrein-Related Peptidase 5. Journal of Surgical Research 2023; 292: 264 doi: 10.1016/j.jss.2023.07.013
|
| 2 |
Xing Luo, Yi Duan, Jinwei He, CongGai Huang, Jun Liu, Yifan Liu, Mengdei Xu, Qiong Dai, Zhihui Yang. Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1429018
|
| 3 |
Jing Yue, Dingqian Hao, Yingzheng Wang, Jinhao Guo, Shengyang Liu, Linghui Meng, Jianliang Liu. The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors. Biomedicine & Pharmacotherapy 2024; 175: 116635 doi: 10.1016/j.biopha.2024.116635
|